Real Estate / REIT - Healthcare FacilitiesUpdated 2026-05-10 22:07 UTC

BME/YADR stock hub

BME/YADR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/YADRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

119.7M

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/YADR

In the news

Latest news · BME/YADR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.8P50 18.7P75 25.9

Trailing P/E9.3

P25 9.7P50 14.2P75 24.9

ROE9.5

P25 1.7P50 4.8P75 9.9

ROIC3.6

P25 1.5P50 2.9P75 4.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/YADR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

EUR

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	95
Employees Change	5%
Employees Change Percent	5.56
Enterprise value	EUR 220.3M
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	REIT - Healthcare Facilities
Isin	ES0105405007
Last refreshed	2026-05-10
Market cap	EUR 119.7M
Price	EUR 10
Price currency	EUR
Rev Per Employee	188,863.16x
Sector	Real Estate
Sic	6513
Symbol	bme/YADR
Website	https://adrianocare.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.72%
EV Earnings	17.16x
EV/EBIT	24.06x
EV/EBITDA	24.04x
EV/Sales	12.28x
P/B ratio	0.89x
P/E ratio	9.35x
P/S ratio	6.67x
PE Ratio3 Y	19.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	51.02%
EBITDA Margin	51.06%
Gross margin	98.19%
Gross Profit	EUR 17.6M
Net Income	EUR 12.8M
Net Income Growth3 Y	15.68%
Pretax Margin	76.11%
Profit Margin	71.53%
Profit Per Employee	EUR 135,095
ROA	2.13
Roa5y	1.25
ROCE	5.45
ROE	9.47
Roe5y	5.21
ROIC	3.55
Roic5y	2.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.29%
Cagr3y	2.94%
EPS Growth3 Y	15.63
Revenue Growth	10.16x
Revenue Growth Q	0.39x
Revenue Growth3 Y	10.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.07
Assets	EUR 268.2M
Cash	EUR 6.9M
Debt	EUR 107.4M
Debt EBITDA	EUR 11.73
Debt Equity	EUR 0.8
Equity	EUR 134.8M
Interest Coverage	2.05
Liabilities	EUR 133.5M
Net Cash	EUR -100.6M
Net Cash By Market Cap	EUR -84.03
Net Debt EBITDA	EUR 10.98
Net Debt Equity	EUR 0.75
Tangible Book Value	EUR 130.5M
Tangible Book Value Per Share	EUR 10.88
WACC	3.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.11
Net Working Capital	EUR -535,000
Quick ratio	0.1
Working Capital	EUR -89.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	120%
Dividend Growth Years	3%
Dividend per share	EUR 1.1
Dividend Years	3
Dividend Yield	11%
Ex Div Date	2025-06-17
Last Dividend	EUR 0.89
Payout Frequency	Annual
Payout Ratio	102.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.29%
200-day SMA	10.06
3Y total return	9.07%
50-day SMA	10.07
50-day SMA vs 200-day SMA	50over200
All Time High	11.1
All Time High Change	-9.91%
All Time High Date	2021-06-24
All Time Low	8.3
All Time Low Change	20.47%
All Time Low Date	2024-05-30
ATR	0.01
Beta	-0.04
Beta1y	0.13
Beta2y	0.06
Ch YTD	1.01
High52	10.4
High52 Date	2026-02-24
High52ch	-3.85%
Low52	9.2
Low52 Date	2025-05-27
Low52ch	8.7%
Ma50ch	-0.71%
Price vs 200-day SMA	-0.62%
RSI	8.14
RSI Monthly	47.32
RSI Weekly	43.95
Sharpe ratio	0.47x
Sortino ratio	1.58
Total Return	11%
Tr YTD	1.01
Tr1m	-0.99%
Tr3m	-3.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 9.2M
Operating margin	51.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	11,969,399
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	29.85x
Bv Per Share	11.24
Ch1m	-0.99
Ch1y	-0.99
Ch3m	-3.85
Ch3y	-5.66
Ch6m	-1.96
Change	0%
Close	10
Depreciation Amortization	7,000
EBIT	EUR 9.2M
EBITDA	EUR 9.2M
EPS	EUR 1.07
F Score	4
Financing CF	-12,989,000
Fiscal Year End	December
Graham Number	16.44745
Graham Upside	64.47
Income Tax	EUR 822,000
Investing CF	6,191,000
Is Primary Listing	1
Last Report Date	2024-12-31
Lynch Fair Value	EUR 16.78
Lynch Upside	67.76
Ma150	10.13
Ma150ch	-1.27%
Ma20	10
Ma20ch	0%
Net CF	-1,163,000
P OCF Ratio	21.24
Payment Date	2025-06-19
Ppne	242,933,000
Price Date	2026-05-08
Price EBITDA	EUR 13.07
Ptbv Ratio	0.92
Relative Volume	3.22x
Revenue	17,942,000x
Tax By Revenue	4.58x
Tax Rate	6.02%
Tr6m	-1.96%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/YADR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+11.0%

$1.10 annual per share

Payout ratio

+102.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+11.0%

Next ex-dividend date: 2025-06-17

Performance

BME/YADR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

BME/YADR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

8.1

Below 30: short-term oversold

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

-0.04

Less volatile than the market

Sharpe ratio

0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/YADR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/YADR stock rating?

bme/YADR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/YADR analysis?

The full report lives at /stocks/bme/YADR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/YADR?

The latest report frames bme/YADR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/YADR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.